Behavioral pharmacology of neuropeptides related to melanocortins and the neurohypophyseal hormones

European Journal of Pharmacology

Volumn 375, Issue 1-3, 1999, Pages 1-11

  De Wied, David ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aging; Behaviour; Cardiovascular control; Melanocortin; Neurohypophyseal hormone; Neuropeptide; Pro opiomelanocortin (POMC); Regeneration; Thermoregulation

Indexed keywords

2 AMINO 4 (METHYLSULFONYL)BUTYRYLGLUTAMYLHISTIDYLPHENYLALANYL DEXTRO LYSYLPHENYLALANINE; ARGIPRESTOCIN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN; CORTICOTROPIN[4-10]; DYNORPHIN; ENDORPHIN; ENDORPHIN DERIVATIVE; ENKEPHALIN; ENKEPHALIN DERIVATIVE; INTERMEDIN; MELANOCORTIN; MELANOCORTIN RECEPTOR; MELATONIN; NALOXONE; NALTREXONE; NEUROHORMONE; NEUROHYPOPHYSIS HORMONE; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NEUROPHYSIN; OPIATE RECEPTOR; OXYTOCIN; PHENCYCLIDINE; PROOPIOMELANOCORTIN; TACHYKININ DERIVATIVE; UNINDEXED DRUG; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

AGING; ANIMAL EXPERIMENT; BEHAVIOR; NONHUMAN; PRIORITY JOURNAL; RAT; REGENERATION; REVIEW; THERMOREGULATION;

EID: 0033052990     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00339-8     Document Type: Article

References (85)

1. Adan, R.A.H., 1999. Effects of melanocortin in the nervous system. In: Cone, R.D. (Ed.), Receptors. Humana Press, in press.
2. Adan R.A.H., Gispen W.H. Brain melanocortin receptors: from cloning to function. Peptides. 18:1997;1279-1287.
3. Akil H., Young E., Watson S.J., Coy D.H. Opiate binding properties of naturally occurring N- and C-terminus modified beta-endorphin. Peptides. 2:1981;289-292.
4. Alescio-Lautier B., Soumireu-Mourat B. Role of vasopressin in learning and memory in the hippocampus. Prog. Brain Res. 119:1998;501-521.
5. Auwerx J., Staels B. Leptin. Lancet. 351:1998;737-742.
6. Bijlsma W.A., Jennekens F.G., Schotman P., Gispen W.H. Effects of corticotrophin (ACTH) on recovery of sensorimotor function in the rat: structure-activity study. Eur. J. Pharmacol. 76:1981;73-79.
7. Brinton R.D., Brownson E.A. Vasopressin-induction of cyclic AMP in cultured hippocampal neurons. Brain Res. Dev. Brain Res. 71:1993;101-105.
8. Brinton R.D., Gonzalez T.M., Cheung W.S. Vasopressin-induced calcium signaling in cultured hippocampal neurons. Brain Res. 667:1994;151-159.
9. Burbach, J.P.H., 1986a. Proteolytic conversion and vasopressin in the brain. In: Ganten, D., Pfaff, D. (Eds.), Current Topics in Neuroendocrinology, Vol. 6, Neurobiology of Oxytocin. Springer-Verlag, Berlin, pp. 55-90.
10. Burbach, J.P.H., 1986b. Action of proteolytic enzymes on lipotropins and endorphins: biosynthesis, biotransformation and fate. In: De Wied, D., Gispen, W.H., Van Wimersma Greidanus, Tj.B. (Eds.), Neuropeptides and Behavior: 1. CNS Effects of ACTH, MSH and Opioid Peptides. Int. Encyclopedia Pharmacol. Therap. Pergamon, Oxford, pp. 43-76.
11. Burbach, J.P.H., Lebouille, J.L.M., Wang, X.-C., 1986. Metabolic conversion of pro-opiomelanocortin peptides by brain peptidases: ACTH, α-MSH and β-endorphin. In: De Wied, D., Ferrari, W. (Eds.), Central Actions of ACTH and Related Peptides. Fidia Research Series, Liviana Press, Padova, pp. 53-68.
12. Burbach J.P.H., Schoots O., Hernando F. Biochemistry of vasopressin fragments. Prog. Brain Res. 119:1998;127-136.
13. Catania A., Lipton J.M. α-Melanocyte stimulating hormone in the modulation of host reactions. Endocrinol. Rev. 14:1993;564-576.
14. Cheung C.C., Clifton D.K., Steiner R.A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology. 138:1997;4489-4492.
15. Cottrell, G.A., Nyakas, C., Bohus, B., De Wied, D., 1983. In: Endröczi, E., De Wied, D., Angelucci, L. (Eds.), Integrative Neurohumoral Mechanisms. Developments in Neuroscience, Vol. 16. Elsevier Biomedical Press, Amsterdam, pp. 91-97.
16. Croiset G., De Wied D. ACTH: a structure-activity study on pilocarpine-induced epilepsy. Eur. J. Pharmacol. 229:1992;211-216.
17. Davis K.L., Kahn R.S., Grant K., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry. 148:1991;1474-1486.
18. Deeter L.B., Martin L.W., Lipton J.M. Antipyretic properties of centrally administered α-MSH fragments in the rabbit. Peptides. 9:1988;1285-1288.
19. De Kloet E.R., Voorhuis T.A., Burbach J.P.H., De Wied D. Autoradiographic localization of binding sites for the arginine-vasopressin (VP) metabolite, VP4-9, in rat brain. Neurosci. Lett. 56:1985;7-11.
20. De Wied D., Jolles J. Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiol. Rev. 62:1982;976-1059.
21. De Wied D., Wolterink G. Structure-activity studies on the neuroactive and neurotropic effects of neuropeptides related to ACTH. Ann. N.Y. Acad. Sci. 525:1989;130-140.
22. De Wied, D., Joëls, M., Burbach, J.P.H., De Jong, W., De Kloet, E.R., Gaffori, O.W.J., Urban, I.J.A., Van Ree, J.M., Van Wimersma Greidanus, Tj.B., Veldhuis, H.D., Versteeg, D.H.G., Wiegant, V.M., 1988. Vasopressin effects on the central nervous system. In: Conn, P.M., Negro Villar, A. (Eds.), Peptide Hormones: Effects and Mechanisms of Action. CRC Press, Boca Raton, FL, pp. 97-140.
23. De Wied D., Elands J., Kovács G.L. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor? Proc. Natl. Acad. Sci. U.S.A. 88:1991;1494-1498.
24. De Wied D., Diamant M., Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front. Neuroendocrinol. 14:1993;251-302.
25. Dhawan B.N., Cesselin F., Raghubir R., Reisine T., Bradley P.B., Portoghese P.S., Hamon M. International Union of Pharmacology: XII. Classification of opioid receptors. Pharmacol. Rev. 48:1996;567-592.
26. Du Y.-C., Yan Q.-W., Qiao L.-Y. Function and molecular basis of action of vasopressin 4-8 and its analogues in rat brain. Prog. Brain Res. 119:1998;163-175.
27. Dyer J.K., Philipsen H.L., Tonnaer J.A., Hermkens P.H., Haynes L.W. Melanocortin analogue Org 2766 binds to rat Schwann cells, upregulates NGF low affinity receptor p75, and releases neurotrophic activity. Peptides. 16:1995;515-522.
28. Elands J., De Kloet E.R., De Wied D. Neurohypophyseal hormone receptors: relation to behavior. Prog. Brain Res. 91:1992;459-464.
29. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
30. Fekete M., De Wied D. Naltrexone-insensitive facilitation and naltrexone-sensitive inhibition of passive avoidance behavior of the ACTH-(4-9) analog (ORG 2766) are located in two different parts of the molecule. Eur. J. Pharmacol. 81:1982;441-448.
31. Ferrari W. Behavioral changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte stimulating hormone. Nature. 181:1958;925-926.
32. Flood J.F., Morley J.E. Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation. Peptides. 10:1989;963-966.
33. Gaffori O., Van Ree J.M. Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats. Neuropharmacology. 24:1985;237-244.
34. Gee C.E., Chen C.L.C., Roberts J.L., Thompson R., Watson S.J. Identification of proopiomelanocortin neurons in the rat hypothalamus by in situ cDNA-mRNA hybridization. Nature. 306:1983;374-375.
35. Gispen W.H., Wiegant V.M., Greven H.M., De Wied D. The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: structure-activity studies. Life Sciences. 17:1975;645-653.
36. Gispen W.H., De Koning P., Kuiters R.P.F., Van der Zee C.E.E.M., Verhaagen J. On the neurotrophic action of melanocortins. Prog. Brain Res. 72:1987;319-331.
37. Greven, H.M., De Wied, D., 1980. Structure and behavioural activity of peptides related to corticotrophin and lipotropic. In: De Wied, D., Van Keep, P.A. (Eds.), Hormones and the Brain. MTP Press, Lancaster, pp. 115-127.
38. Gu B.X., Du Y.C. Arginine-vasopressin C-terminal peptide stimulates inositol phospholipid metabolism in rat hippocampus. Acta Biochim. Biophys. Sin. 23:1991;331-337.
39. Hammonds R.G., Nicolas P., Li C.H. β-Endorphin-(1-27) is an antagonist of β-endorphin analgesia. Proc. Natl. Acad. Sci. U.S.A. 81:1984;1389-1390.
40. Hol E.M., Hermens W.T.J.M.C., Verhaagen J., Gispen W.H., Bär P.R. α-MSH but not ORG 2766 induces expresson of c-fos in cultured rat spinal cord cells. NeuroReport. 4:1993;651-654.
41. Holdeman M., Lipton J.M. Antipyretic activity of a potent α-MSH analog. Peptides. 6:1985;273-275.
42. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38:1995;3454-3461.
43. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
44. Ingram C.D., Ciobanu R., Coculescu I.L., Tanasescu R., Coculescu M., Mihai R. Vasopressin neurotransmission and the control of circadian rhythms in the suprachiasmatic nucleus. Prog. Brain Res. 119:1998;351-364.
45. Joëls M., Urban I.J.A. Amino acid neurotransmission between fimbria-fornix fibers and neurons in the lateral septum of the rat: a microiontophoretic study. Exp. Neurol. 84:1984;126-139.
46. 2+ transients in cells cultured from rat circumventricular organs. Brain Res. 673:1995;349-355.
47. Kask A., Rago L., Wikberg J.E., Schioth H.B. Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur. J. Pharmacol. 360:1998;15-19.
48. Kovács G.L., De Wied D. Peptidergic modulation of learning and memory processes. Pharmacol. Rev. 46:1994;269-291.
49. Lande S., Witter A., De Wied D. Pituitary peptides. An octapeptide that stimulates conditioned avoidance acquisition in hypophysectomized rats. J. Biol. Chem. 246:1971;2058-2062.
50. 1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J. Neurosci. 15:1995;4250-4258.
51. Lolait S.J., O'Carroll A.M., Mahan L.C., Felder C.C., Button D.C., Young W.S. 3rd, Mezey E., Brownstein M.J. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc. Natl. Acad. Sci. U.S.A. 92:1995;6783-6787.
52. Macaluso A., McCoy D., Ceriani G., Watanabe T., Biltz J., Catania A., Lipton J.M. Antiinflammatory influences of α-MSH molecules: central neurogenic and peripheral actions. J. Neurosci. 14:1994;2377-2382.
53. Mercer J.G., Moar K.M., Hoggars N. Localization of leptin receptor (Ob-R) messenger ribonucleic acid in rodent hindbrain. Endocrinology. 139:1998;29-34.
54. Mihai R., Coculescu M., Wakerley J.B., Ingram C.D. The effects of [Arg8]vasopressin and [Arg8]vasotocin on the firing rate of suprachiasmatic neurons in vitro. Neuroscience. 62:1994;783-792.
55. Narita M., Tseng L.F. Evidence for the existence of the beta-endorphin-sensitive "epsilon-opioid receptor" in the brain: the mechanisms of epsilon-mediated antinociception. Jpn. J. Pharmacol. 76:1998;233-253.
56. Niesink R.J., Van Ree J.M. Analysis of the facilitatory effect of the ACTH (4-9) analog ORG 2766 on active social contact in rats. Life Sci. 5:1984;961-970.
57. Pettibone D.J., Friedinger R.M. Discovery and development of non-peptide antagonists of peptide hormone receptors. Biochem. Soc. Trans. 25:1997;1051-1057.
58. Plantinga L.C., Verhaagen J., Edwards P.M., Hali M., Brakkee J.H., Gispen W.H. Pharmacological evidence for the involvement of endogenous α-MSH-like peptides in peripheral nerve regeneration. Peptides. 16:1995;319-324.
59. Popik P., Van Ree J.M. Neurohypophyseal peptides and social recognition in rats. Prog. Brain Res. 119:1998;415-436.
60. Radhakishun F.S., Westerink B.H., van Ree J.M. Dopamine release in the nucleus accumbens of freely moving rats determined by on-line dialysis: effects of apomorphine and the neuroleptic-like peptide desenkephalin-gamma-endorphin. Neurosci. Lett. 89:1988;328-334.
61. Reijmers L.G., Van Ree J.M., Spruijt B.M., Burbach J.P.H., De Wied D. Vasopressin metabolites: a link between vasopressin and memory? Prog. Brain Res. 119:1998;523-535.
62. Ronken E., Tonnaer J.A., De Boer T., Wiegant V.M. Autoradiographic evidence for binding sites for des-enkephalin-gamma-endorphin (ORG 5878) in rat forebrain. Eur. J. Pharmacol. 162:1989;189-191.
63. Roselli-Refuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., Entwistle M.-L., Simerly R.B., Cone R.D. Identification of a receptor for gamma melanotropin and other pro-opioelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8856-8860.
64. 1 receptor in the brain: pharmacology and putative functions. Eur. J. Pharmacol., in press.
65. Schiöth H.B., Mutulis F., Muceniece R., Prusis P., Wikberg J.E.S. Discovery of novel melanocortin 4 receptor selective MSH analogues. Br. J. Pharmacol. 124:1998;75-82.
66. Seeley R.J., Yagaloff K.A., Fisher S.L., Burn P., Thiele T.E., Van Dijk G., Baskin D.G., Schwartz M.W. Melanocortin receptors in leptin effects. Nature. 390:1997;349.
67. Spruijt B.M. An ACTH 4-9 analog enhances social attention in aging rats: a longitudinal study. Neurobiol. Aging. 13:1992;153-158.
68. Spruijt B.M., Van Hooff J.A.R.A.M., Gispen W.H. Ethology and neurobiology of grooming behavior. Physiol. Rev. 72:1992;825-852.
69. Stark H., Burbach J.P.H., Van der Kleij A.A., De Wied D. In vivo conversion of vasopressin after microinjection into limbic brain areas of rats. Peptides. 10:1989;717-720.
70. Strand F.L., Williams K.A., Alves S.E., Antonawich F.J., Lee T.S., Lee S.J., Kume J., Zuccarelli L.A. Melanocortins as factors in somatic neuromuscular growth and regrowth. Pharmacol. Ther. 62:1994;1-27.
71. Tatro, J.B., 1990. Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and alpha-melanocyte stimulating hormone. Brain Res., 536, 124, 132.
72. Tatro J.B., Reichlin S. Specific receptors for α-MSH are widely distributed in tissues of rodents. Endocrinology. 121:1987;1900-1907.
73. Terenius L., Gispen W.H., De Wied D. ACTH-like peptides and opiate receptors in the rat brain: structure-activity studies. Eur. J. Pharmacol. 33:1975;395-399.
74. Van der Zee C.E., Brakkee J.H., Gispen W.H. Putative neurotrophic factors and functional recovery from peripheral nerve damage in the rat. Br. J. Pharmacol. 103:1991;1041-1046.
75. Van Ree J.M., De Wied D. Behavioral effects of non-opioid fragments of beta-endorphin. Prog. Clin. Biol. Res. 192:1985;277-284.
76. Van Ree J.M., Otte A.P. Effects of (Des-Tyr1)-gamma-endorphin and alpha-endorphin as compared to haloperidol and amphetamine on nucleus accumbens self-stimulation. Neuropharmacology. 19:1980;429-434.
77. Van Ree J.M., Bohus B., Csontos K.M., Gispen W.H., Greven H.M., Nijkamp F.P., Opmeer F.A., De Rotte G.A., Van Wimersma Greidanus Tj.B., Witter A., De Wied D. Behavioral profile of γ-MSH: relationship with ACTH and β-endorphin action. Life Sci. 28:1981;2875-2878.
78. Van Ree, J.M., Gerrits, M.A.F.M., Vanderschuren, L.J.M.J., 1999. Opioids, reward and addiction. An encounter of biology, psychology and medicine. Pharmacol. Rev., in press.
79. Vergoni A.V., Bertolini A., Mutulis F., Wikberg J.E., Schioth H.B. Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats. Eur. J. Pharmacol. 362:1998;95-101.
80. Verhoeven W.M.A., Van Ree J.M., Heezius-van Bentum A., De Wied D., Van Praag H.M. Antipsychotic properties of Des-enkephalin-gamma-endorphin in treatment of schizophrenic patients. Arch. Gen. Psychiatry. 39:1982;648-654.
81. Versteeg D.H.G., Van Bergen P., Adan R.A.H., De Wildt D.J. Melanocortins and cardiovascular regulation. Eur. J. Pharmacol. 360:1998;1-14.
82. Wang X.C., Burbach J.P.H., Verhoef J.C., De Wied D. Proteolytic conversion of arginine-vasotocin by synaptic membranes from rat and chicken brain. Brain Res. 275:1983;83-90.
83. Watson S.J., Richard C.W. III, Barchas J.D. Adrencorticotropin in rat brain: immunocytochemical localization in cells and axons. Science. 200:1978;1180-1182.
84. Wiegant V.M., Ronken E., Kovács G., De Wied D. Endorphins and schizophrenia. Prog. Brain Res. 93:1992;433-453.
85. Wolterink G., Van Zanten E., Kamsteeg H., Radhakishun F.S., Van Ree J.M. Functional recovery after destructionof dopamine systems in the nucleus accumbens of rats: II. Facilitation by the ACTH-(4-9) analog Org 2766. Brain Res. 15:1990;101-108.